{"id":"W2805937849","doi":"10.1001/jamaneurol.2018.1212","title":"Evaluation of Galcanezumab for the Prevention of Episodic Migraine","year":2018,"lang":"en","type":"article","venue":"JAMA Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Montreal Neurological Institute and Hospital; University of South Carolina; Eli Lilly and Company","keywords":"Migraine; Discontinuation; Medicine; Placebo; Aura; Adverse effect; Population; Randomized controlled trial; Anesthesia; Pediatrics; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07623788688618421,"score_gpt":0.3733392311157892,"score_spread":0.297101344229605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}